About Neuroprex
Neuroprex is a company based in Santa Clara (United States) founded in 2012 by Janice Huang. Neuroprex has raised $50 thousand across 4 funding rounds from investors including European Union, National Science Foundation and EIC Fund. Neuroprex offers products and services including NPX. Neuroprex operates in a competitive market with competitors including Flow Neuroscience, NeuroStar, Magstim, Soterix Medical and NeuroQore, among others.
- Headquarter Santa Clara, United States
- Founders Janice Huang
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Neuroprex Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$50 K (USD)
in 4 rounds
-
Latest Funding Round
$224.93 K (USD), Grant
Jul 15, 2018
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neuroprex
Neuroprex offers a comprehensive portfolio of products and services, including NPX.
Wearable for treating drug-resistant depression and PTSD via magnetic stimulation.
People of Neuroprex
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Neuroprex
Neuroprex has successfully raised a total of $50K across 4 strategic funding rounds. The most recent funding activity was a Grant round of $224.93 thousand completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neuroprex
Neuroprex has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, National Science Foundation and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Neuroprex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neuroprex
Investment portfolio details for Neuroprex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neuroprex
Detailed financials for Neuroprex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuroprex Comparisons
Peer comparison for Neuroprex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neuroprex
Neuroprex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flow Neuroscience, NeuroStar, Magstim, Soterix Medical and NeuroQore, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a wearable device for stress and anxiety management
|
|
| Locked | Locked | Locked |
Non-invasive TMS therapy is provided for major depressive disorder treatment.
|
|
| Locked | Locked | Locked |
Neurotechnology solutions for EEG, TMS, and tDCS are developed.
|
|
| Locked | Locked | Locked |
Non-invasive neuromodulation devices for mood disorders are manufactured.
|
|
| Locked | Locked | Locked |
Monophasic rTMS systems for depression treatment are developed by NeuroQore.
|
Detailed competitors of Neuroprex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuroprex
Complete news archive for Neuroprex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neuroprex
Neuroprex was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Neuroprex is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Janice Huang is the current CEO of Neuroprex. They have also founded this company.
Neuroprex is a funded company, having raised a total of $50K across 4 funding rounds to date.
Neuroprex was founded in 2012 and is located in Santa Clara, United States. Wearable devices are developed by the company within the medical technology sector to address neurological conditions. A Transcranial Magnetic Stimulation (TMS) device is provided, featuring star-shaped electromagnetic coils integrated into a surface pain reduction shield layer. Nerve activities in brain and body tissues linked to depression, PTSD, and related disorders are targeted for modulation through these operations.
Neuroprex's top competitors include NeuroStar, Flow Neuroscience and Magstim.
Neuroprex offers NPX.
Neuroprex has 3 investors. Key investors include European Union, National Science Foundation, and EIC Fund.